Can Urinary CTX-II Be a Biomarker for Knee Osteoarthritis?

Arthroplasty
doi 10.1186/s42836-020-0024-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Comparison of Urinary CTX-II Levels in Postmenopausal Women With Knee Osteoarthritis With or Without Osteoporosis

Turkiye Klinikleri Journal of Medical Sciences
Medicine
2012English

Can Osteopontin Be Considered a Biomarker for Endometriosis?

Revista de Chimie
SurfacesMaterials ScienceEngineeringMaterials ChemistryFilmsCoatingsChemistry
2017English

SAT0498 the Performance of Urinary Collagen Type II C-Telopeptide (UCTX-II) in Knee Osteoarthritis: A Meta-Analysis

2017English

Urinary CTX-II Concentrations Are Elevated and Associated With Knee Pain and Function in Subjects With ACL Reconstruction

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2012English

Can Osteoarthritis Be Treated With Light?

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2013English

SLC2A4 Polymorphisms Can Be a New Molecular Biomarker for Sports Genomics

Annals of Applied Sport Science
Sports MedicineHospitality ManagementPhysical TherapyApplied PsychologyLeisureRehabilitationOrthopedicsSports TherapyTourismSocial Sciences
2017English

Potential Diagnostic Value of a Type X Collagen Neo-Epitope Biomarker for Knee Osteoarthritis

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

Biomarkers of Bone and Cartilage Turnover CTX-I and CTX-II Predict Total Joint Replacements in Osteoarthritis

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

Urinary Nerve Growth Factor Levels Could Be a Biomarker for Overactive Bladder Symptom: A Meta-Analysis

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy